Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New stent trial aims to improve outcomes for tough heart blockages

NCT ID NCT07491107

First seen Apr 03, 2026 · Last updated May 20, 2026 · Updated 8 times

Summary

This study will track 2000 people with complex coronary artery disease who receive the Inspiron EVO drug-eluting stent during a procedure to open blocked heart arteries. The goal is to see how well the stent works and how safe it is in real-world patients with challenging blockages. Participants will be followed to monitor heart-related events like heart attacks or the need for repeat procedures.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)

    Porto Alegre, Rio Grande do Sul, 90610000, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.